Andrew Hall

Chief Executive Officer of Issuer at Consano Bio.

Raised on Consano Bio filings

$51.7M

of $65.7M offered across 2 Form D filings

Company

Biotech · Burlington, MA

Biologic therapies for orthopedic injuries

Biologic therapies for orthopedic injuries

Consano Bio Form D filings
Filed	Security	Sold of offered	Filing
Mar 20, 2026	Equity	$34.8M/ $48.9M	Form D
Dec 12, 2025	Security to be acquired	$16.8M/ $16.8M	Form D

Also named on Consano Bio filings